摘要 |
A method of using a surrogate, preferably <99m>Tc-MDP, for a therapeutic agent (for example, <166>Ho-EDTMP or preferably <166>Ho-DOTMP) to calculate the dosimetry for the therapeutic dose for bone marrow ablation therapy is disclosed. The advantages of this use of a surrogate <i>in lieu</i> of the therapeutic agent is lower cost, less exposure to high radiation levels, and length of the half-life, while maintaining the biodistribution in the total skeleton. |
申请人 |
MCCULLOUGH, STEVEN;WENDT, RICHARD, E., III;SIMON, JAIME |
发明人 |
MCCULLOUGH, STEVEN;WENDT, RICHARD, E., III;SIMON, JAIME |